Juliet Carbon

Juliet Carbon

UNVERIFIED PROFILE

Are you Juliet Carbon?   Register this Author

Register author
Juliet Carbon

Juliet Carbon

Publications by authors named "Juliet Carbon"

Are you Juliet Carbon?   Register this Author

14Publications

391Reads

16Profile Views

Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma.

Cancer Res 2014 Feb 17;74(4):1032-44. Epub 2013 Dec 17.

Authors' Affiliations: Division of Surgical Oncology, Department of Surgery, Hamon Center for Therapeutic Oncology Research; Departments of Pathology and Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Neurological Surgery, University of California San Francisco, San Francisco, California; and Department of Surgery, Ajou University School of Medicine, Suwon, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-2800DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944405PMC
February 2014

Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.

Clin Cancer Res 2012 Sep 24;18(18):5031-42. Epub 2012 Jul 24.

Division of Surgical Oncology, Department of Surgery, The Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-0453DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777527PMC
September 2012

Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation.

PLoS One 2012 14;7(2):e31384. Epub 2012 Feb 14.

Division of Surgical Oncology, Department of Surgery and Pharmacology, Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0031384PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279359PMC
July 2012

r84, a novel therapeutic antibody against mouse and human VEGF with potent anti-tumor activity and limited toxicity induction.

PLoS One 2010 Aug 6;5(8):e12031. Epub 2010 Aug 6.

Division of Surgical Oncology, Department of Surgery, Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012031PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917360PMC
August 2010

Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer.

Cancer Res 2010 Apr 23;70(7):2852-61. Epub 2010 Mar 23.

Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical School, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-3892DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848888PMC
April 2010

Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.

Dis Model Mech 2010 Jan-Feb;3(1-2):57-72. Epub 2009 Dec 9.

Hamon Center for Therapeutic Oncology Research, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1242/dmm.003228DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806901PMC
March 2010

Tumor-derived intercellular adhesion molecule-1 mediates tumor-associated leukocyte infiltration in orthotopic pancreatic xenografts.

Exp Biol Med (Maywood) 2010 Feb;235(2):263-70

Division of Surgical Oncology, Department of Surgery, Hamon Center for Therapeutic Oncology Research, the University of Texas Southwestern Medical School, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1258/ebm.2009.009215DOI Listing
February 2010

Secreted protein acidic and rich in cysteine as a regulator of murine ovarian cancer growth and chemosensitivity.

Am J Obstet Gynecol 2009 Feb 6;200(2):180.e1-7. Epub 2008 Nov 6.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-8593, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2008.08.047DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709016PMC
February 2009

The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer.

BMC Cancer 2008 Nov 27;8:352. Epub 2008 Nov 27.

Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical School, Dallas, TX 75390-8593, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-8-352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627916PMC
November 2008

Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature.

Clin Cancer Res 2007 Jan;13(1):323-30

Hamon Center for Therapeutic Oncology Research and Department of Surgery, University of Texas Southwestern Medical Center, Dallas 75390-8593, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-1313DOI Listing
January 2007

Functional analysis of the matricellular protein SPARC with novel monoclonal antibodies.

J Histochem Cytochem 2004 Jun;52(6):723-33

Department of Vascular Biology, The Hope Heart Institute, Seattle, Washington 98101, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1369/jhc.3A6153.2004DOI Listing
June 2004

Expression and characterization of murine hevin (SC1), a member of the SPARC family of matricellular proteins.

J Histochem Cytochem 2004 Jun;52(6):735-48

Department of Vascular Biology, The Hope Heart Institute, Seattle, Washington 98104-2046, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1369/jhc.3A6245.2004DOI Listing
June 2004

SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling.

J Cell Biochem 2003 Mar;88(4):802-11

Department of Vascular Biology, The Hope Heart Institute, Seattle, Washington 98104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcb.10424DOI Listing
March 2003